P2Y₁₂ Inhibition beyond Thrombosis: Effects on Inflammation

Area of Science:

• Pharmacology
• Immunology
• Cardiovascular Medicine

Background:

• P2Y12 receptor is crucial for platelet activation and a target for antithrombotic drugs.
• Platelet activation plays a significant role in inflammation.
• Nonplatelet P2Y12 receptors on immune and vascular cells influence inflammatory responses.

Purpose of the Study:

• To investigate the anti-inflammatory role of P2Y12 receptor inhibition.
• To explore the biological and clinical impact beyond antithrombotic effects.
• To discuss mechanisms and evidence in inflammatory diseases.

Main Methods:

• Literature review of P2Y12 receptor's role in inflammation.
• Analysis of molecular and cellular mechanisms (cytokine release, platelet-leukocyte interactions, NETs).
• Summary of clinical evidence in inflammatory conditions.

Main Results:

• P2Y12 inhibition demonstrates anti-inflammatory potential.
• Mechanisms include modulation of cytokine release, platelet-leukocyte interactions, and neutrophil extracellular trap formation.
• Evidence suggests benefits in sepsis, acute lung injury, asthma, atherosclerosis, and cancer.

Conclusions:

• P2Y12 receptor antagonists possess anti-inflammatory properties.
• Inhibition impacts key inflammatory pathways and cellular interactions.
• Clinical benefits are observed across diverse inflammatory diseases, suggesting broader therapeutic applications.